Surgery rates in Japan around market-entry milestones of advanced therapies for Crohn's disease and ulcerative colitis: an interrupted time-series study using a large-scale Japanese claims database
Authors: Mori, Mitsuhiro; Nakao, Yoko M; Kozu, Takumi; Kawakami, Koji
Source journal: Current medical research and opinion (2026-11-16)
DOI: 10.1080/03007995.2026.2761162
Abstract
OBJECTIVE: Whether the market entry of newer advanced therapies is associated with changes in surgery rates for inflammatory bowel disease in routine clinical practice remains unclear. We aimed to describe surgery rates for Crohn's disease and ulcerative colitis in Japan around the market-entry milestones of advanced therapies. METHODS: This interrupted time-series study used a large-scale, outpatient-inclusive health insurance claims database from Japan (2012-2020). Prespecified intervention points were the market-entry months of ustekinumab for Crohn's disease (May 2017) and vedolizumab for ulcerative colitis (November 2018). The primary outcome was monthly surgery rates, modeled using segmented Poisson regression with an offset for patients at risk. RESULTS: The cohorts included 5,411 patients with Crohn's disease and 37,052 with ulcerative colitis. Surgery rates declined during the pre-intervention period (incidence rate ratios [95% confidence intervals]: Crohn's disease, 0.993 [0.988-0.999]; ulcerative colitis, 0.994 [0.988-1.001]). No evidence of a level or post-intervention trend change was observed at the intervention points (Crohn's disease: level change, 0.924 [0.708-1.202]; trend change, 1.000 [0.984-1.015]; ulcerative colitis: level change, 0.883 [0.588-1.309]; trend change, 1.008 [0.984-1.032]). CONCLUSION: Surgery rates showed a gradual pre-existing decline with no detectable level or trend change around these market-entry milestones. These findings suggest that changes in surgical rates may occur gradually rather than as an abrupt shift around a single market-entry milestone.
Related topics
Related open access articles
- The Differentiation and Roles of inflammatory Cytokine in the initiation of Inflammatory Bowel Diseases (IBD)
- The Regulations of Gene Expressions by 1α,25(OH)2D3 in Patients with Inflammatory Bowel Diseases
- Transportation degrades the quality of plaster cast models in virtual surgical planning -Is it time for direct intraoral scanning?
- Seizures episodes after local anaesthesia in oral surgery: case report
- The Effects Of Nitrous Oxide On Postoperative Pain, Nausea Vomiting and Intraoperative Haemodynamics in Robotic Gynecologic Surgery
- Implementation of an Enhanced Recovery After Surgery (ERAS) Clinical Pathway Using Lean Six Sigma Principles: A Framework for Ongoing Quality Improvement
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.